These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19933973)

  • 21. APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment.
    Ballard CG; Morris CM; Rao H; O'Brien JT; Barber R; Stephens S; Rowan E; Gibson A; Kalaria RN; Kenny RA
    Neurology; 2004 Oct; 63(8):1399-402. PubMed ID: 15505155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies.
    Maki PM
    Menopause; 2013 Jun; 20(6):695-709. PubMed ID: 23715379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The joint effect of apolipoprotein E epsilon4 and MRI findings on lower-extremity function and decline in cognitive function.
    Carmelli D; DeCarli C; Swan GE; Kelly-Hayes M; Wolf PA; Reed T; Guralnik JM
    J Gerontol A Biol Sci Med Sci; 2000 Feb; 55(2):M103-9. PubMed ID: 10737693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stroke and apolipoprotein E epsilon4 are independent risk factors for cognitive decline: A population-based study.
    Dik MG; Deeg DJ; Bouter LM; Corder EH; Kok A; Jonker C
    Stroke; 2000 Oct; 31(10):2431-6. PubMed ID: 11022076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective analysis of the association between estrogen receptor gene variants and the risk of cognitive decline in elderly women.
    Ryan J; Carrière I; Amieva H; Rouaud O; Berr C; Ritchie K; Scarabin PY; Ancelin ML
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1763-8. PubMed ID: 23932494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No differences in performance on test of working memory and executive functioning between healthy elderly postmenopausal women using or not using hormone therapy.
    Grigorova M; Sherwin BB
    Climacteric; 2006 Jun; 9(3):181-94. PubMed ID: 16766432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old.
    Juva K; Verkkoniemi A; Viramo P; Polvikoski T; Kainulainen K; Kontula K; Sulkava R
    Neurology; 2000 Jan; 54(2):412-5. PubMed ID: 10668704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphisms.
    Parmenter BA; Denney DR; Lynch SG; Middleton LS; Harlan LM
    Mult Scler; 2007 Jan; 13(1):25-32. PubMed ID: 17294608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults.
    O'Hara R; Yesavage JA; Kraemer HC; Mauricio M; Friedman LF; Murphy GM
    J Am Geriatr Soc; 1998 Dec; 46(12):1493-8. PubMed ID: 9848808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial.
    Maki PM; Gast MJ; Vieweg AJ; Burriss SW; Yaffe K
    Neurology; 2007 Sep; 69(13):1322-30. PubMed ID: 17893293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of apolipoprotein E genotype on the risk of cognitive deterioration in moderate drinkers and smokers.
    Dufouil C; Tzourio C; Brayne C; Berr C; Amouyel P; Alpérovitch A
    Epidemiology; 2000 May; 11(3):280-4. PubMed ID: 10784244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An update on the cognitive impact of clinically-used hormone therapies in the female rat: models, mazes, and mechanisms.
    Acosta JI; Hiroi R; Camp BW; Talboom JS; Bimonte-Nelson HA
    Brain Res; 2013 Jun; 1514():18-39. PubMed ID: 23333453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lifetime estrogen exposure and cognition in late life: the Cache County Study.
    Matyi JM; Rattinger GB; Schwartz S; Buhusi M; Tschanz JT
    Menopause; 2019 Dec; 26(12):1366-1374. PubMed ID: 31613825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive benefits of hormone therapy: cardiovascular factors and healthy-user bias.
    Wharton W; Dowling M; Khosropour CM; Carlsson C; Asthana S; Gleason CE
    Maturitas; 2009 Nov; 64(3):182-7. PubMed ID: 19879073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of APOE status on cognitive maintenance in healthy elderly persons.
    Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
    Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women.
    Steffens DC; Norton MC; Plassman BL; Tschanz JT; Wyse BW; Welsh-Bohmer KA; Anthony JC; Breitner JC
    J Am Geriatr Soc; 1999 Oct; 47(10):1171-5. PubMed ID: 10522948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4.
    Burkhardt MS; Foster JK; Laws SM; Baker LD; Craft S; Gandy SE; Stuckey BG; Clarnette R; Nolan D; Hewson-Bower B; Martins RN
    J Alzheimers Dis; 2004 Jun; 6(3):221-8. PubMed ID: 15201477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation.
    Slooter AJ; Tang MX; van Duijn CM; Stern Y; Ott A; Bell K; Breteler MM; Van Broeckhoven C; Tatemichi TK; Tycko B; Hofman A; Mayeux R
    JAMA; 1997 Mar; 277(10):818-21. PubMed ID: 9052712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of hormone therapy on depressive symptoms and cognitive functions in women with Alzheimer disease: a 12 month randomized, double-blind, placebo-controlled study of low-dose estradiol and norethisterone.
    Valen-Sendstad A; Engedal K; Stray-Pedersen B; ; Strobel C; Barnett L; Meyer N; Nurminemi M
    Am J Geriatr Psychiatry; 2010 Jan; 18(1):11-20. PubMed ID: 20094015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early postmenopausal hormone therapy may prevent cognitive impairment later in life.
    Bagger YZ; Tankó LB; Alexandersen P; Qin G; Christiansen C;
    Menopause; 2005; 12(1):12-7. PubMed ID: 15668595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.